RADICALS-HD: Reflections before the Results are Known.

Parker, C C; Clarke, N W; Catton, C; Kynaston, H; Cook, A; Cross, W; Davidson, C; Goldstein, C; Logue, J; Maniatis, C; Petersen, P M; Neville, P; Payne, H; Persad, R; Pugh, C; Stirling, A; Saad, F; Parulekar, W R; Parmar, M K B; Sydes, M R

Parker, C C; Clarke, N W; Catton, C; Kynaston, H; Cook, A; Cross, W; Davidson, C; Goldstein, C; Logue, J; Maniatis, C; Petersen, P M; Neville, P; Payne, H; Persad, R; Pugh, C; Stirling, A; Saad, F; Parulekar, W R; Parmar, M K B; Sydes, M R.

Afiliação

Parker CC; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: chris.parker@rmh.nhs.uk.
Clarke NW; Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK; Department of Urology, Salford Royal Hospitals, Manchester, UK.
Catton C; Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Kynaston H; Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Cross W; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Davidson C; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.
Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Logue J; Oncology, The Christie Hospital, Manchester, UK.
Maniatis C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Petersen PM; Department of Oncology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Neville P; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Payne H; Oncology, University College London Hospitals, London, UK.
Persad R; Bristol Urological Institute, North Bristol Hospitals, Bristol, UK.
Pugh C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Stirling A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Saad F; University of Montreal Hospital Center (CHUM), Montréal, Canada.
Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.
Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.

Clin Oncol (R Coll Radiol) ; 34(9): 593-597, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35810050

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google